产品编号：D528807
产品规格：2.5mg
产品价格：面议
| 标准品编号: | D528807 |
| 名称: | Dolutegravir Sodium Salt-d6 |
| 别名: | Dolutegravir sodium-d6; GSK 1349572VIP(LA)d6; N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide Sodium Salt-d6 |
| 参考CAS: | 1051375-19-9 |
| 分子式: | C₂₀H₁₂D₆F₂N₃NaO₅ |
| 分子量: | 447.4 |
| 种类: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Dolutegravir Sodium Salt-d6, is the labeled analogue of Dolutegravir Sodium Salt (D528805), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. |
| 参考文献 | |
